FDA Says Drug, Device Reviewers Ineligible for $25,000 Buyout

The FDA told its staff Monday that employees responsible for reviewing drugs, medical devices, and tobacco products aren’t eligible to take a $25,000 voluntary buyout to depart from the agency.

The employees—who also include the agency’s inspectors, investigators, and cybersecurity experts—are excluded from the Voluntary Separation Incentive Payments offered this week by the US Department of Health and Human Services, according to an email sent to FDA staff from the Office of Human Capital Management that was obtained by Bloomberg Law.

The health department last week received authorization from the Office of Personnel Management to offer time-limited buyouts of up ...